MODELING PROCESS OF PALLIATIVE PHARMACEUTICAL CARE AS A COMPONENT OF PHARMACEUTICAL SAFETY AT THE LOCAL LEVEL


Cite item

Full Text

Abstract

The importance of the pharmaceutical safety of the palliative care system, good timing of its delivery, accessibility and quality have been actively discussed in the professional environment only for the latest 4–5 years. Despite the urgency of the direction in question, the necessary number of pharmacies licensed for trafficking in narcotic drugs,psychotropic substances and their precursors has not yet been determined. The aim of the article is the optimization process of palliative pharmaceutical care system aimed at timely and prompt provision of patients with opioi analgesics in the right assortment and the required volume in Novokuznetsk of the Kemerovo region. Materials and methods.To carry out the research, the following materials and methods have been used: the content analysis of outpatient cards of 17 polyclinics in five districts of Novokuznetsk (750 cards), photo-timing data of pharmaceutical workers on prescription of drugs, psychotropic substances and their precursors (39,964 prescriptions), sociological survey(questionnaires) of 101 district therapists, social workers and patients (their legal representatives) for the period of 2014-2017, cluster modeling of the palliative care process. Results and discussion. The retrospective content analysis of 750 outpatient cards, photo-timing data for 39,964 prescriptions for narcotic drugs, psychotropic substances and their precursors for the period of 2014–2017 have shown an increase in the load per pharmacist. The introduction of a cluster model of interaction between medical and pharmaceutical staff at the outpatient stage of palliative care minimizesthe time spent on performing auxiliary procedures. Conclusion. In the conditions of an industrial center for 100 thousand inhabitants, at least one pharmacy organization dealing with the release of narcotic drug and psychotropic substances and their precursors is necessary for the proper and stable provision of patients in need of palliative care. Such a specialized pharmacy should be located in the territory with a good transport interchange, and its specialists are obliged to regularly raise the professional qualifications in the sphere of palliative care provision. One of the effectiveways to improve the quality and timeliness of the choice of anesthesia tactics, the necessary adjustment is the cluster organization of palliative care, based on the close professional relationship of medical and pharmaceutical personnel, ensuring the proper pharmaceutical safety of patients.

About the authors

I. A. Tueva

Novokuznetsk State Institute for Advanced Training of Doctors – a branch of The Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuous Professional Training” of The Ministry of Health of The Russian Federation

Email: tueva37@mail.ru

L. N. Geller

Federal State Budget Educational Institution of Higher Education “Irkutsk State Medical University” of the Ministry of Health of the Russian Federation

Email: levng@mail.ru

A. L. Myimrina

Novokuznetsk State Institute for Advanced Training of Doctors – a branch of The Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuous Professional Training” of The Ministry of Health of The Russian Federation

Email: Anna812481@mail.ru

L. A. Escheva

Novokuznetsk State Institute for Advanced Training of Doctors – a branch of The Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuous Professional Training” of The Ministry of Health of The Russian Federation

Email: Esheva.l@mail.ru

I. V. Vidyasova

Novokuznetsk State Institute for Advanced Training of Doctors – a branch of The Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuous Professional Training” of The Ministry of Health of The Russian Federation

Email: irinavlada2203@mail.ru

References

  1. Мошкова Л.В., Коржавых Э.А., Кузнецов Д.А. Современные проблемы фармацевтической безопасности //Жизнь без опасностей. Здоровье. Профилактика. Долголетие. 2011. № 1. С. 20–27.
  2. Кузнецов Д.А. Разработка подходов к противодействию угрозам финансовой безопасности в фармации //Вестн. новых медицинских технологий. 2011. Т. 21. № 2. С. 455–457.
  3. Кузнецов Д.А. Исследование угроз силовой безопасности при осуществлении фармацевтической деятельности // Современная медицина и фармацевтика: анализ и перспективы развития: Мат-лы III Междунар.науч.-практ. конф. М., 2012. С. 30–31.
  4. Белоусов Б.Ю., Колбин А.С., Бурбелло А.Т., Загородникова К.А. Специалист по фармакологической безопасности в фармацевтической компании // Качественная клиническая практика. 2010. № 1. С. 81–86.
  5. Лившиц С.А., Гуров А.Н. Опыт работы с жалобами граждан в связи с неудовлетворенностью медицинской помощью // Вестник Росздравнадзора. 2017. №2. С. 80–84.
  6. Паллиативная помощь взрослым и детям: организация и профессиональное обучение / Сборник документов ВОЗ и ЕАПП. М.: Р. Валент, 2014. 180 с.
  7. Каприн А.Д., Абузарова, Хороненко В.Э., Алексеева Г.С., Костин А.Д., Старинский В.В., Алексеев Б.Я.Фармакотерапия хронического болевого синдрома у взрослых пациентов при оказании паллиативной помощи в стационарных и амбулаторно-поликлинических условиях: методические рекомендации. Москва,2015. 47 с.
  8. Туева И.А., Дементьева Л.А. Потребность в фармацевтических кадрах, занимающихся хранением и реализацией наркотических средств и психотропных веществ в аптеках / Тез. докл. XIХ Рос. нац. конгр.«Человек и лекарство». М., 2014. С. 342.
  9. Информационные материалы по вопросам медицинского применения наркотических средств, психотропных веществ и других препаратов, подлежащих предметно-количественному учету (с изменениями и дополнениями, внесенными в нормативные акты, на 14.01.2017 г.): для руководителей и административного персонала медицинских и аптечных организаций, медицинских и фармацевтических работников, дистрибьюторских организаций: В 2 ч. М.: ИД «АБД-пресс», 2017. 228 с.
  10. Каминская И.А., Мошкова Л.В. Доступность наркотических средств и психотропных веществ для медицинских целей // Новая аптека. 2015. №10. С. 56–61.
  11. Петрухина И.К., Ягудина Р.И., Куркин В.А., Агапов А.И. Анализ финансовых затрат при реализации программ льготного лекарственного обеспечения населения // Известия Самарского научного центра РАН.2015. Т. 17. № 5 (2). С. 399–402.
  12. . Петрухина И.К., Ягудина Р.И., Куркин В.А. Экономический анализ затрат при осуществлении отдельных видов социальной фармацевтической помощи // Современные проблемы науки и образования. 2015. № 5.URL: http://www.scienceeducation.ru/128-21520 (дата обращения: 17.10.2017)
  13. Ягудина Р.И., Петрухина И.К. Анализ реализации региональных программ льготного лекарственного обеспечения населения / Доклад на Межведомственной конференции «Финансирование системы здравоохранения» – «ФинЗдрав 2016». М.: 13-14 декабря 2016 г. URL: http://finzdrav.com/2016 (дата обращения:17.10.2017)
  14. Beach M., Inui Т. the Relationship-Centered Care Research Team. Relationship-centered care: A constructive reframing // Journal of General Internal Medicine. 2006. Vol. 21. P. 53–58.
  15. Wager J., Zernikow B., Drake R., Papadatou D., Hubner-Mohler B., Bluebond-Langner M. International Multiprofessional Course in Pediatric Palliative Care: Benefits and Challenges // Journal of palliative Medicine. 2013. Vol. 16. Is. 1. P. 96–99.
  16. Gamondi C., Larkin P., Payne S. Core competencies in palliative care: an EAPC White Paper on palliative care education – part 1 // European Journal of Palliative Care. 2013. Vol. 2. P. 86–91.
  17. Sarti A., Bourbonnais F., Landriault A., Sutherland St., Cardinal P. An Interhospital, Interdisciplinary Needs Assessment of Palliative Care in a Community Critical Care Context. Journal of Palliative Care. 2015. Vol. 31. Is. 4. P. 234–242.
  18. Discala S., Basri D., Vartan C., Silverman M. Use of Topical Morphine to Relieve Painful Pressure Ulcers //Consult Pharm. 2018. Vol. 33. Is. 4. P. 215–221.
  19. Collins A., Sundararajan V., Burchell J., Millar J., McLachlan S., Krishnasamy M., Le B., Mileshkin L., Hudson P., Philip J. Transition Points for the Routine Integration of Palliative Care in Patients with Advanced Cancer //J Pain Symptom Manage. 2018. Vol. 3924. Is. 18. P. 30182–30189.
  20. Cedar S., White M., Atwal A. The efficacy of complementary therapy for patients receiving palliative cancer care // Int J Palliat Nurs. 2018. Vol. 24. Is. 3. P. 146–151.
  21. Neergaard M., Brogaard T., Vedsted P., Jensen A. Asking terminally ill patients about their preferences concerning place of care and death // Int J Palliat Nurs. 2018. Vol. 24. Is. 3. P. 124–131.
  22. Shinall M. Jr. The Evolving Moral Landscape of Palliative Care // Health Aff (Millwood). 2018. Vol. 37. Is. 4. P. 670–673.
  23. Shiokawa M., Kawamura K. The 10th Annual Meeting of the Japanese Society for Pharmaceutical Palliative Care and Sciences // Yakugaku Zasshi. 2018. Vol. 138. Is. 4. P. 523–524.
  24. McCarroll C. Increasing Access to Palliative Care Services in the IntensiveCare Unit // Dimens Crit Care Nurs. 2018. Vol. 37. Is. 3. P. 180–192.
  25. La Frenais F., Bedder R., Vickerstaff V., Stone P., Sampson E. Temporal Trends in Analgesic Use in Long-Term Care Facilities: A Systematic Review of International Prescribing // J Am Geriatr Soc. 2018. Vol. 66. Is. 2. P. 376–382.

Copyright (c) 2018 Tueva I.A., Geller L.N., Myimrina A.L., Escheva L.A., Vidyasova I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies